Skip to main content

British Thyroid Foundation joins pioneering Connect Immune Research partnership

The patient support charity British Thyroid Foundation has joined the group of organisations collaborating on research into the causes of autoimmune conditions.
JDRF logo placeholder for author profile picture
Kate Lawton 11 October 2022

British Thyroid Foundation and Connect Immune Research logos

The patient support charity British Thyroid Foundation has joined the group of organisations collaborating on research into the causes of autoimmune conditions.

Autoimmune conditions occur when the body’s immune system begins attacking its own cells. Often, people have more than one autoimmune condition, fuelling the idea that there are common underlying biological mechanisms across different autoimmune conditions.

What is Connect Immune Research?

Connect Immune Research is a ground-breaking initiative launched in 2018 by JDRF, the MS Society, Versus Arthritis and the British Society for Immunology. It brings together organisations that research autoimmune conditions to understand how autoimmune disorders are linked.

What is the British Thyroid Foundation?

The British Thyroid Foundation (BTF) committing to the project now is testament to how the autoimmune research community views this pivotal partnership. Scientists coming together from different fields broadens the scope of research, leading to faster and more innovative outcomes. Connect Immune Research now has even more experts working collaboratively. This accelerates its mission to find the root causes of autoimmunity and develop treatments for people living with autoimmune conditions.

Julia Priestley, CEO (Development) of the BTF, said: “We are delighted to join Connect Immune Research, which is such an important network of organisations with common interests. We look forward to working together and sharing resources to encourage much-needed research in this area.”

The BTF is a patient support organisation dedicated to helping people live better with thyroid disease by providing evidence-based information and a support network. BTF funds vital research into thyroid disease to improve understanding, diagnosis and treatment of thyroid disorders.

Autoimmune thyroid diseases affect millions in UK

Professor Marian Ludgate from the Thyroid Research Group at Cardiff University School of Medicine said: “Autoimmune thyroid diseases, such as Hashimoto’s thyroiditis and Graves’ disease, are the most commonly occurring autoimmune diseases. They affect millions of people of all ages in the UK. Unfortunately, even though the prevalence of thyroid autoimmunity is increasing, treatments for most patients haven’t changed in decades.”

Now the British Thyroid Foundation have joined the collaboration, Connect Immune Research is made up of the following organisations:

  • JDRF
  • The British Society for Immunology
  • The MS Society
  • Versus Arthritis
  • Alopecia UK
  • The Psoriasis and Psoriatic Arthritis Alliance
  • Coeliac UK
  • Bowel Research UK
  • The British Thyroid Foundation

Investigating autoimmune conditions together

Rachel Connor, Director of Research Partnerships at JDRF, said: “We know that there are many people who live with more than one autoimmune condition, and many more people who have family members who are affected by other autoimmune conditions. So, it makes sense to investigate what these conditions have in common. The more autoimmune conditions we have represented in the Connect Immune Research partnership, the more we can ensure this research fits the needs of everyone affected by autoimmunity.”

Related news

Read more
Professor Doug Melton
Treatment research
21 October 2021

Type 1 diabetes research progress: New stem cell therapy can reduce need for insulin by 91%

The first person to receive a new stem cell-derived therapy for type 1 diabetes, VX-880, has been found to need 91% less daily insulin 90 days after receiving just half the target dose.

Read more
Insulin vials
3 March 2022

New partnership provides affordable insulin for all in the USA

An historic deal has been agreed between JDRF International and partners, to deliver lower-cost insulin across the USA from 2024 to everyone – regardless of insurance status.

Read more
Two girls with skipping ropes and hoola-hoops outside a red brick house
22 July 2022

JDRF and DigiBete partner up to support young people living with type 1 diabetes

We’re delighted to announce that we’re going to be working together with DigiBete to provide children, young people and their families with the information and support they need to live life well with type 1 diabetes.

Read more
Reprogramming type 1 diabetes cells to produce insulin again
Cure research
29 July 2022

JDRF researchers reprogramme donor type 1 pancreas cells to produce insulin

In a project funded by JDRF, scientists have turned on a gene in cells from a person with type 1 diabetes that allows them to produce insulin again.